abrdn plc grew its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 89.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,764,107 shares of the biopharmaceutical company’s stock after acquiring an additional 1,772,887 shares during the quarter. Gilead Sciences […]
Roman Butler Fullerton & Co Sells 240 Shares of Gilead Sciences, Inc (NASDAQ:GILD) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Eukles Asset Management cut its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.2% in the fourth quarter, HoldingsChannel.com reports. The firm owned 14,218 shares of the biopharmaceutical company’s stock after selling 469 shares during the period. Eukles Asset Management’s holdings in Gilead Sciences were worth $1,152,000 as of its most recent SEC […]
Xponance Inc. grew its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 186,443 shares of the biopharmaceutical company’s stock after purchasing an additional 13,667 shares during […]
Eukles Asset Management lessened its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,218 shares of the biopharmaceutical company’s stock after selling 469 shares during the period. Eukles Asset Management’s holdings […]